Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

European Journal of Immunology

Volumn 30, Issue 7, 2000, Pages 2038-2047

  Kontoyiannis, Dimitris ^a   Kollias, George ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Autoantibody; Autoimmunity; Cytokine; Knockout; Lupus

Indexed keywords

AUTOANTIBODY; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; GENETIC ENGINEERING; GLOMERULONEPHRITIS; HELPER CELL; HEMIZYGOSITY; HETEROZYGOTE; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENETIC ENGINEERING; HUMANS; LUPUS NEPHRITIS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NZB; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033947471     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K     Document Type: Article

References (47)

1. Howie, J. B. and Helyer, B. J., The immunology and pathology of NZB mice. Adv. Immunol. 1968. 9: 215-266.
2. Vyse, T. J. and Kotzin, B. L., Genetic susceptibility to systemic lupus erythematosus. Annu. Rev. Immunol. 1998. 16: 261-292.
3. Knight, J. G. and Adams, D. D., Three genes for lupus nephritis in NZB x NZW mice. J. Exp. Med. 1978. 147: 1653-1660.
4. Hirose, S., Ueda, G., Noguchi, K., Okada, T., Sekigawa, I., Sato, H. and Shirai, T., Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice. Eur. J. Immunol. 1986. 16: 1631-1633.
5. Rozzo, S. J., Vyse, T. J., Drake, C. G. and Kotzin, B. L., Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis. Proc. Natl. Acad. Sci. USA 1996. 93: 15164-15168.
6. Jacob, C. O. and McDevitt, H. O., Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 1988. 331: 356-358.
7. Jongeneel, C. V., Acha-Orbea, H. and Blankenstein, T., A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain. J. Exp. Med. 1990. 171: 2141-2146.
8. Jacob, C. O., Lee, S. K. and Strassmann, G., Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J. Immunol. 1996. 156: 3043-3050.
9. Vassalli, P., The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992. 10: 411-452.
10. Cope, A. P., Liblau, R. S., Yang, X. D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G. and McDevitt, H. O., Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 1997. 185: 1573-1584.
11. Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway, C. A. J. and Flavell, R. A., Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 1996. 184: 1963-1974.
12. Jacob, C. O., Hwang, F., Lewis, D. G. and Stall, A. M., Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine 1991. 3: 551-561.
13. Bendtzen, K., Morling, N., Fomsgaard, A., Svenson, M., Jakobsen, B., Odum, N. and Svejgaard, A., Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand. J. Immunol. 1988. 28: 599-606.
14. Gordon, C. and Wofsy, D., Effects of recombinant murine tumor necrosis factor-alpha on immune function. J. Immunol. 1990. 144: 1753-1758.
15. Chiang, B. L., Bearer, E., Ansari, A., Dorshkind, K. and Gershwin, M. E., The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J. Immunol. 1990. 145:94-101.
16. Vyse, T. J., Drake, C. G., Rozzo, S. J., Roper, E., Izui, S. and Kotzin, B. L., Genetic linkage of IgG autoantibody production in relation to lupus nephritis in New Zealand hybrid mice. J. Clin. Invest 1996. 98: 1762-1772.
17. Klinman, D. M. and Steinberg, A. D., Inquiry into murine and human lupus. Immunol. Res. 1995. 144: 157-193.
18. Wofsy, D. and Seaman, W. E., Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 1987. 138: 3247-3253.
19. + T cells is required to suppress autoimmunity. J. Immunol. 1992. 149: 3083-3088.
20. Cawley, D., Chiang, B. L., Naiki, M., Ansari, A. A. and Gershwin, M. E., Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice. J. Immunol. 1993. 150: 2467-2477.
21. Paul, W. E. and Ohara, J., B-cell stimulatory factor-1/interleukin 4. Annu. Rev. Immunol. 1987. 5: 429-459.
22. Prud'homme, G. J., Balderas, R. S., Dixon, F. J. and Theofilopoulos, A. N., B cell dependence on and response to accessory signals in murine lupus strains. J. Exp. Med. 1983. 157: 1815-1827.
23. Nakajima, A., Hirose, S., Yagita, H. and Okumura, K., Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 1997. 158: 1466-1472.
24. Nygard, N. R., McCarthy, D. M., Schiffenbauer, J. and Schwartz, B. D., Mixed haplotypes and autoimmunity. Immunol. Today 1993. 14: 53-56.
25. Fujimura, T., Hirose, S., Jiang, Y., Kodera, S., Ohmuro, H., Zhang, D., Hamano, Y., Ishida, H., Furukawa, S. and Shirai, T., Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int. Immunol. 1998. 10: 1467-1472.
26. Vyse, T. J., Halterman, R. K., Rozzo, S. J., Izui, S. and Kotzin, B. L., Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus. Proc. Natl. Acad. Sci. USA 1999. 96: 8098-8103.
27. Ghatak, S., Sainis, K., Owen, F. L. and Datta, S. K., T-cell-receptor beta- and I-A beta-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB x SWR crosses. Proc. Natl. Acad. Sci. USA 1987. 84: 6850-6853.
28. Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J. and Wakeland, E. K., Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994. 1: 219-229.
29. Brennan, D. C., Yui, M. A., Wuthrich, R. P. and Kelley, V. E., Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J. Immunol. 1989. 143: 3470-3475.
30. Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S. and Howard, M., Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 1994. 179: 305-310.
31. McSorley, S. J., Soldera, S., Malherbe, L., Carnaud, C., Locksley, R. M., Flavell, R. A. and Glaichenhaus, N., Immunological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells. Immunity 1997. 7: 401-409.
32. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
33. Speiser, D. E., Sebzda, E., Ohteki, T., Bachmann, M. F., Pfeffer, K., Mak, T. W. and Ohashi, P. S., Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 1996. 26: 3055-3060.
34. Wallgren, A., Festin, R., Gidlof, C., Dohlsten, M., Kalland, T. and Totterman, T. H., Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Blood 1993. 82: 1230-1238.
35. Lens, S. M., Tesselaar, K., den Drijver, B. F., van Oers, M. H. and van Lier, R. A., A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. J. Immunol. 1996. 156: 507-514.
36. Douni, E. and Kollias, G., A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J. Exp. Med. 1998. 188: 1343-1352.
37. Zhou, T., Edwards, C. K., Yang, P., Wang, Z., Bluethmann, H. and Mountz, J. D., Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 1996. 156: 2661-2665.
38. Botto, M., Dell'Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P. and Walport, M. J., Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998. 19: 56-59.
39. Paul, E. and Carroll, M. C., SAP-less chromatin triggers sysstemic lupus erythematosus. Nat. Med. 1999. 5: 607-608.
40. Bopst, M., Haas, C., Car, B. and Eugster, H. P., The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. Eur. J. Immunol. 1998. 28: 4130-4137.
41. Peschon, J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B. and Mohler, K. M., TNF Receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 1998. 160: 943-952.
42. van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M., Woody, J. N., Hartung, H. P. and Polman, C. H., Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996. 47: 1531-1534.
43. Sandborn, W. J. and Hanauer, S. B., Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm. Bowel. Dis. 1999. 5: 119-133.
44. Pasparakis, M., Alexopoulou, L., Episkopou, V. and Kollias, G., Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 1996. 184: 1397-1411.
45. Bemelmans, M. H., Gouma, D. J. and Buurman, W. A., LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J. Immunol. 1993. 151: 5554-5562.
46. Berden, J. H., Hang, L., McConahey, P. J. and Dixon, F. J., Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J. Immunol. 1983. 130: 1699-1705.
47. Defranco, A. L., Reveche, E. S., Asofsky, R. and Paul, W. E., Frequency of B lymphocytes responsive to anti-immunoglobulin. J. Exp. Med. 1982. 155: 1523-1536.